Company Introduction – Neodynamics
On the 6th of December you have the opportunity to meet Anna Eriksrud, CEO of Neodynamics, when she gives an introduction to the company. During the webinar it will be possible to ask questions.
NeoDynamics recently started a subsidiary in Germany, NeoDynamics AB GmbH, to grow in this important market for the company's innovative biopsy system #NeoNavia. The first results from the German PULSE study were presented at the prestigious British Society of Breast Radiology (BSBR) annual scientific meeting. The study shows that NeoNavia can be used successfully and with a low frequency of side effects for sampling in the axilla.
NeoDynamics AB is a Swedish medical technology company. The company is engaged in offering precision cancer management for improved patient care. It has developed the NeoNavia biopsy system, which utilizes a patented micropulse technology to simplify and improve precision in biopsy sampling in breast cancer patients.
Disclaimer: HC Andersen Capital receives payment from NeoDynamics for a Digital IR / Corporate Visibility subscription agreement.